valeant pharma stock

Valeant pharma stock

Shares in Quebec-based Valeant Pharmaceuticals, once one of Canada's most valuable companies, plummeted 13 per cent on Tuesday.

Bill Ackman has officially quit Valeant Pharmaceuticals. The founder of the hedge fund Pershing Square on Monday sold his investment in the company and announced his plan to step down from the board. Once a stock market darling, Valeant has been falling since September after the company began to face scrutiny over its pricing strategy and its use of a secret specialty pharmacy called Philidor. When Philidor's existence — which had been kept from investors — was exposed its entire business model came under scrutiny from Wall Street, and its practices under investigation. Read next. US Markets Loading Close icon Two crossed lines that form an 'X'.

Valeant pharma stock

See More. Compare Symbols. Your browser of choice has not been tested for use with Barchart. If you have issues, please download one of the browsers listed here. Log In Menu. Stocks Futures Watchlist More. Advanced search. Watchlist Portfolio. Investing News Tools Portfolio. Stocks Stocks. Options Options. Collar Spreads Collar Spread. Futures Futures. Currencies Currencies.

Need More Chart Options?

.

It looks like you are not logged in. Click the button below to log in and keep track of your recent history. Markets Crypto Forex Commodities Futures. US Tech 17, Dow Jones 39,

Valeant pharma stock

See More. Compare Symbols. Your browser of choice has not been tested for use with Barchart. If you have issues, please download one of the browsers listed here. Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier.

Wooden wall letter holder

Full Chart. Currencies Forex Market Pulse. News Barchart. Shares tumble to a six-year low as the company cuts its forecast. Watchlist Portfolio. Social Sharing. Tools Member Tools. European Trading Guide Historical Performance. Thanks for signing up! Investing News Tools Portfolio. ETFs Market Pulse.

All market data will open in new tab is provided by Barchart Solutions. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice.

The drugmaker in recent months has been mired in scandal, the subject of drug-pricing investigations and improper accounting allegations. Right-click on the chart to open the Interactive Chart menu. Lydia Ramsey Pflanzer and Andy Kiersz. March 14, Log In Sign Up. Current Rating See More. Options Market Pulse. Thanks for signing up! Facebook Email icon An envelope. Site News.

0 thoughts on “Valeant pharma stock

Leave a Reply

Your email address will not be published. Required fields are marked *